Similar articles for PMID: 17227303

Year	Number of Results
1991	1
1995	1
1996	1
1999	1
2000	1
2001	1
2004	2
2005	16
2006	11
2007	7
2008	5
2009	1
2010	2
2011	1
2014	2
2024	0

1

Lack of EGFR gene mutations in exons 19 and 21 in esophageal (Barrett's) adenocarcinomas.

Pühringer-Oppermann FA, Stein HJ, Sarbia M. Pühringer-Oppermann FA, et al. Dis Esophagus. 2007;20(1):9-11. doi: 10.1111/j.1442-2050.2007.00630.x. Dis Esophagus. 2007. PMID: 17227303

2

Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas.

Kwak EL, Jankowski J, Thayer SP, Lauwers GY, Brannigan BW, Harris PL, Okimoto RA, Haserlat SM, Driscoll DR, Ferry D, Muir B, Settleman J, Fuchs CS, Kulke MH, Ryan DP, Clark JW, Sgroi DC, Haber DA, Bell DW. Kwak EL, et al. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4283-7. doi: 10.1158/1078-0432.CCR-06-0189. Clin Cancer Res. 2006. PMID: 16857803 Free PMC article.

3

Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer.

Rosell R, Ichinose Y, Taron M, Sarries C, Queralt C, Mendez P, Sanchez JM, Nishiyama K, Moran T, Cirauqui B, Mate JL, Besse B, Reguart N, Perez M, Sanchez JJ. Rosell R, et al. Lung Cancer. 2005 Oct;50(1):25-33. doi: 10.1016/j.lungcan.2005.05.017. Lung Cancer. 2005. PMID: 16011858

4

Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus.

Phillips WA, Russell SE, Ciavarella ML, Choong DY, Montgomery KG, Smith K, Pearson RB, Thomas RJ, Campbell IG. Phillips WA, et al. Int J Cancer. 2006 May 15;118(10):2644-6. doi: 10.1002/ijc.21706. Int J Cancer. 2006. PMID: 16380997 Free article.

5

Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.

Mu XL, Li LY, Zhang XT, Wang MZ, Feng RE, Cui QC, Zhou HS, Guo BQ. Mu XL, et al. Clin Cancer Res. 2005 Jun 15;11(12):4289-94. doi: 10.1158/1078-0432.CCR-04-2506. Clin Cancer Res. 2005. PMID: 15958609

6

P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.

Schneider PM, Stoeltzing O, Roth JA, Hoelscher AH, Wegerer S, Mizumoto S, Becker K, Dittler HJ, Fink U, Siewert JR. Schneider PM, et al. Clin Cancer Res. 2000 Aug;6(8):3153-8. Clin Cancer Res. 2000. PMID: 10955797 Clinical Trial.

7

p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.

Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C. Bian YS, et al. Mod Pathol. 2001 May;14(5):397-403. doi: 10.1038/modpathol.3880324. Mod Pathol. 2001. PMID: 11353048

8

p53 gene mutations in Barrett's epithelium and esophageal cancer.

Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B, Roth JA. Casson AG, et al. Cancer Res. 1991 Aug 15;51(16):4495-9. Cancer Res. 1991. PMID: 1868473

9

Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.

Rygiel AM, Milano F, Ten Kate FJ, Schaap A, Wang KK, Peppelenbosch MP, Bergman JJ, Krishnadath KK. Rygiel AM, et al. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1380-5. doi: 10.1158/1055-9965.EPI-07-2734. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18559552

10

Clinico-pathological and biological significance of tyrosine kinase domain gene mutations and overexpression of epidermal growth factor receptor for lung adenocarcinoma.

Ohtsuka K, Ohnishi H, Furuyashiki G, Nogami H, Koshiishi Y, Ooide A, Matsushima S, Watanabe T, Goya T. Ohtsuka K, et al. J Thorac Oncol. 2006 Oct;1(8):787-95. J Thorac Oncol. 2006. PMID: 17409961 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

49 results

Results by year